LifeMD(LFMD) - 2025 Q4 - Annual Report

FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 LIFEMD, INC. ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from __________________________ to __________________________ Commission file number 001-39785 Securities registered pursuant to Section 12(b) of the Act: ...

LifeMD(LFMD) - 2025 Q4 - Annual Report - Reportify